Skip to main content

University of Exeter Medical School

 Joanne McDermid

Joanne McDermid

Senior Research Fellow

 J.McDermid@exeter.ac.uk

 


Overview

Back to top


Publications

Journal articles

Creese B, Ballard C (In Press). Cost-effectiveness of Dementia Care Mapping in care home settings – Evaluation of a randomised controlled trial. Applied Health Economics and Health Policy
McDermid J, Henley W, Corbett A, Williams G, Fossey J, Clare L, Fox C, Aarsland D, Khan Z, Soto M, et al (2024). Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: a randomized controlled trial. Alzheimers Dement, 20(3), 1797-1806. Abstract.  Author URL.
McDermid J, Ballard C, Khan Z, Aarsland D, Fox C, Fossey J, Clare L, Moniz-Cook E, Soto-Martin M, Sweetnam A, et al (2023). Impact of the Covid-19 pandemic on neuropsychiatric symptoms and antipsychotic prescribing for people with dementia in nursing home settings. Int J Geriatr Psychiatry, 38(1). Abstract.  Author URL.
McDermid J, Da Silva MV, Williams G, Khan Z, Corbett A, Ballard C (2022). A Randomized Controlled Trial of a Digital Adaptation of the WHELD Person-Centered Nursing Home Training Program. J Am Med Dir Assoc, 23(7), 1166-1170. Abstract.  Author URL.
McDermid J, Khan Z, Sweetnam A, Ballard CG (2022). Antipsychotic prescriptions and neuropsychiatric symptoms (NPS) in nursing home (NH)residents with dementia: a comparison of pre‐ and during COVID pandemic. Alzheimer's & Dementia, 18(Suppl 7).
Choi A, Martyr A, Clare L, Fossey J, Khan Z, McDermid J, Ballard C (2022). Impact of Psychotic Symptoms and Concurrent Neuropsychiatric Symptoms on the Quality of Life of People with Dementia Living in Nursing Homes. J Am Med Dir Assoc, 23(9), 1474-1479.e1. Abstract.  Author URL.
Ballard CG, McDermid J, Aarsland D, Khan Z, Sweetnam A (2022). iWHELD, a Novel Digital Non-Pharmacological Intervention with Live Virtual Coaching Reduces Antipsychotic Use in Nursing Home Residents with Dementia Compared to Usual Care in a 16-week RCT. Alzheimer's and Dementia, 18(S8). Abstract.
Perfect D, Griffiths AW, Vasconcelos Da Silva M, Lemos Dekker N, McDermid J, Surr CA (2021). Collecting self-report research data with people with dementia within care home clinical trials: Benefits, challenges and best practice. Dementia (London), 20(1), 148-160. Abstract.  Author URL.
Kelley R, Griffiths AW, Shoesmith E, McDermid J, Couch E, Robinson O, Perfect D, Surr CA (2020). The influence of care home managers on the implementation of a complex intervention: Findings from the process evaluation of a randomised controlled trial of dementia care mapping. BMC Geriatrics, 20(1). Abstract.
Griffiths AW, Kelley R, Garrod L, Perfect D, Robinson O, Shoesmith E, McDermid J, Burnley N, Surr CA (2019). Barriers and facilitators to implementing dementia care mapping in care homes: results from the DCM EPIC trial process evaluation. BMC GERIATRICS, 19  Author URL.
Surr CA, Shoesmith E, Griffiths AW, Kelley R, McDermid J, Fossey J (2019). Exploring the role of external experts in supporting staff to implement psychosocial interventions in care home settings: results from the process evaluation of a randomized controlled trial. BMC Health Serv Res, 19(1). Abstract.  Author URL.
McDermid J, Ballard C (2019). P4‐627: NO IMPROVEMENT IN NURSING HOME CARE FOR PEOPLE WITH DEMENTIA SINCE THE MILLENNIUM. Alzheimer's & Dementia, 15(7S_Part_30), p1568-p1568.
Surr CA, Griffiths AW, Kelley R, Holloway I, Walwyn REA, Martin A, McDermid J, Chenoweth L, Farrin AJ (2019). The Implementation of Dementia Care Mapping in a Randomized Controlled Trial in Long-Term Care: Results of a Process Evaluation. Am J Alzheimers Dis Other Demen, 34(6), 390-398. Abstract.  Author URL.
Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S, Tomkinson EB, et al (2018). Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study. The Lancet Neurology, 17(3), 213-222. Abstract.
Ballard C, Fossey J, Romeo R, McDermid J (2018). F3‐03‐01: EFFICACY, COST‐EFFECTIVENESS AND SUSTAINED ENGAGEMENT OF THE IMPROVING WELL‐BEING AND HEALTH FOR PEOPLE WITH DEMENTIA (WHELD) PERSON‐CENTERED CARE TRAINING PROGRAMME. Alzheimer's & Dementia, 14(7S_Part_18), p999-p999.
McDermid J, Fossey J, Da Silva MV, Ballard C (2018). O4‐03‐06: a RANDOMIZED CONTROLLED TRIAL EVALUATING THE IMPACT OF AN E‐LEARNING INTERVENTION BASED ON THE IMPROVING WELL‐BEING AND HEALTH FOR PEOPLE WITH DEMENTIA (WHELD) PERSON‐CENTRED CARE TRAINING PROGRAMME. Alzheimer's & Dementia, 14(7S_Part_26), p1406-p1406.

Back to top


Edit Profile